These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22100686)

  • 1. Current state of the absorbable metallic (magnesium) stent.
    Waksman R
    EuroIntervention; 2009 Dec; 5 Suppl F():F94-7. PubMed ID: 22100686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assimilating the current clinical data of fully bioabsorbable stents.
    Di Mario C; Borgia F
    EuroIntervention; 2009 Dec; 5 Suppl F():F103-8. PubMed ID: 22100669
    [No Abstract]   [Full Text] [Related]  

  • 4. Everolimus-eluting bioabsorbable stent--Abbot Vascular programme.
    Onuma Y; Piazza N; Ormiston JA; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F98-F102. PubMed ID: 22100687
    [No Abstract]   [Full Text] [Related]  

  • 5. A.R.T.: concept of a bioresorbable stent without drug elution.
    Lafont A; Durand E
    EuroIntervention; 2009 Dec; 5 Suppl F():F83-7. PubMed ID: 22100683
    [No Abstract]   [Full Text] [Related]  

  • 6. Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview.
    Yan J; Bhat VD
    EuroIntervention; 2009 Dec; 5 Suppl F():F80-2. PubMed ID: 22100682
    [No Abstract]   [Full Text] [Related]  

  • 7. Engineering a bioresorbable stent: REVA programme update.
    Pollman MJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F54-7. PubMed ID: 22100677
    [No Abstract]   [Full Text] [Related]  

  • 8. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Absorbable coronary stents. New promising technology].
    Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
    Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings.
    Cottone RJ; Thatcher GL; Parker SP; Hanks L; Kujawa DA; Rowland SM; Costa M; Schwartz RS; Onuma Y
    EuroIntervention; 2009 Dec; 5 Suppl F():F65-71. PubMed ID: 22100679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy.
    Wykrzykowska JJ; Onuma Y; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680
    [No Abstract]   [Full Text] [Related]  

  • 12. The bioabsorption process: tissue and cellular mechanisms and outcomes.
    Vorpahl M; Finn AV; Nakano M; Virmani R
    EuroIntervention; 2009 Dec; 5 Suppl F():F28-35. PubMed ID: 22100673
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents.
    Ghimire G; Spiro J; Kharbanda R; Roughton M; Barlis P; Mason M; Ilsley C; Di Mario C; Erbel R; Waksman R; Dalby M
    EuroIntervention; 2009 Jan; 4(4):481-4. PubMed ID: 19284070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local drug delivery for treatment of coronary and peripheral artery disease.
    Gertz ZM; Wilensky RL
    Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atheroma and coronary bifurcations: before and after stenting.
    Yazdani SK; Nakano M; Otsuka F; Kolodgie FD; Virmani R
    EuroIntervention; 2010 Dec; 6 Suppl J():J24-30. PubMed ID: 21930487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEVO™: a new generation of sirolimus-eluting coronary stent.
    Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C
    EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684
    [No Abstract]   [Full Text] [Related]  

  • 18. Ten-year follow-up of the IGAKI-TAMAI stent. A posthumous tribute to the scientific work of Dr. Hideo Tamai.
    Onuma Y; Garg S; Okamura T; Ligthart J; van Geuns RJ; de Feyter PJ; Serruys PW; Tamai H
    EuroIntervention; 2009 Dec; 5 Suppl F():F109-11. PubMed ID: 22100670
    [No Abstract]   [Full Text] [Related]  

  • 19. Stent thrombosis--risk assessment and prevention.
    Motovska Z; Knot J; Widimsky P
    Cardiovasc Ther; 2010 Oct; 28(5):e92-100. PubMed ID: 20553282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The STENTYS® self-apposing stent in bifurcation lesions.
    Ramcharitar S; Verheye S
    EuroIntervention; 2010 Dec; 6 Suppl J():J151-4. PubMed ID: 21930482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.